Activities of Fagron
Introduction to members of the Executive Committee
Fagron's key figures in one overview
Please find here our annual reports
Presentations and conference calls
Please find here the statutory annual accounts
Prospectus of the Initial Public Offering
Prospectus of the 4.75% bond
Prospectus of the capital increase
Compliance certificates and guarantor lists
Look at the actual share performance
Shareholding declaration obligation
Dividend policy of Fagron
Documents relating to shareholders' meetings
Analysts covering Fagron
Overview of participations
Capital Market Days
Members of the Fagron's Board of Directors
Corporate governance documents
Prospectus of the Initial Public Offering (English version as approved by the Belgian market authority CBFA/BFIC on 11 September 2007).
Download prospectus 11 September 2007
Fagron is the leading global pharmaceutical compounding company, bringing customized pharmaceutical care to hospitals, pharmacies, clinics and patients in 32 countries worldwide.
Sign up to receive our latest press releases.
© Copyright 2013-2017 Fagron.